update desk

aMoon2 raises $660 million, becomes largest Israeli venture capital firm

Israel’s electronic medical records account for 98 percent of the population, going back two decades. The Israeli government recently launched a national project that will invest $272 million in digital health initiatives over the next five years.

Yair Schindel, co-founder and managing partner of aMoon. Credit: Tomer Jacobson.
Yair Schindel, co-founder and managing partner of aMoon. Credit: Tomer Jacobson.

Israeli health fund aMoon2 has raised $660 million, becoming the Jewish state’s largest venture capital firm.

Out of an estimated $1 billion in assets under management on aMoon’s investment platform, the goal of aMoon2, which launched in 2018, is to “harness untapped Israeli HealthTech innovation and capitalize on mid-late stage funding gaps in Israel and around the world. To date, the fund has invested in four Israeli companies and a fifth in Silicon Valley, founded by an Israeli entrepreneur,” according to a company statement.

The initial aMoon fund was founded in 2016 by Marius Nacht, co-founder and chairman of Check Point Software Technologies, and Yair Schindel.

Israel’s electronic medical records account for 98 percent of the population, going back two decades. The Israeli government recently launched a national project that will invest $272 million in digital health initiatives over the next five years.

“The convergence of medicine and technology is generating a wave of innovation capable of redefining medical care—beyond our imagination,” said aMoon’s anchor investor, Marius Nacht, co-founder and chairman of cybersecurity company Check Point Software Technologies. “This presents a unique opportunity both for impacting human life and for the investor community.”

aMoon and Credit Suisse announced in May 2018 a strategic partnership to enable investors with direct access to Israel’s rapidly growing health-tech sector.

“We believe our partnership with aMoon represents an attractive platform for investors, while providing the funding needed for disruptive businesses to drive the advancement of health care,” said Michel Degen, CEO of Credit Suisse Asset Management Switzerland and EMEA.

You have read 3 articles this month.
Register to receive full access to JNS.

Just before you scroll on...

Israel is at war. JNS is combating the stream of misinformation on Israel with real, honest and factual reporting. In order to deliver this in-depth, unbiased coverage of Israel and the Jewish world, we rely on readers like you. The support you provide allows our journalists to deliver the truth, free from bias and hidden agendas. Can we count on your support? Every contribution, big or small, helps JNS.org remain a trusted source of news you can rely on.

Become a part of our mission by donating today
Topics
Comments
Thank you. You are a loyal JNS Reader.
You have read more than 10 articles this month.
Please register for full access to continue reading and post comments.
Never miss a thing
Get the best stories faster with JNS breaking news updates